The phase 4, open-label AGILE trial compared the safety and efficacy of 60-, 45-, and 30-minute pegloticase infusions vs standard 120-minute protocols.

Long-awaited updates to the American College of Rheumatology's (ACR) guideline on systemic lupus erythematosus (SLE) ...

A higher-titer ANA raises the suspicion that something more systemic may be going on,’ said Amanda Mixon, PA-C.

Belimumab is linked to a reduced risk for all-cause mortality compared with azathioprine, methotrexate, and mycophenolate among patients with nonrenal SLE.

Alvotech rated Hold after FDA setback for AVT05. Click for my look at ALVO stock prospects and what would make me upgrade it to Buy.

Current therapies such as biological DMARDs showed promising results in treating rheumatoid arthritis patients, and market penetration is expected to be more in the future and expected to drive market ...

The TL1a inhibitor duvakitug was effective at 14 weeks in patients who had previous exposure to conventional and advanced ...

Valentine Murakatete, a 31-year-old resident of Kibagabaga, began noticing unusual itching on her skin in 2015. What started as a minor irritation soon turned into a burning sensation that spread in ...

Learn more about whether Halozyme Therapeutics, Inc. or Viridian Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether BioMarin Pharmaceutical Inc. or Halozyme Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...